Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers
This draft guidance introduces submitters of De Novo requests to CDRH and CBER the associated content to support De Novo electronic submissions to FDA.